Clene - CLNN Stock Forecast, Price & News

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Clene in the last twelve months. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CLNN shares.
View CLNN analyst ratings or view top-rated stocks.

7 brokers have issued 1 year price objectives for Clene's shares. Their CLNN share price forecasts range from $6.00 to $17.00. On average, they predict the company's stock price to reach $11.43 in the next twelve months. This suggests a possible upside of 868.5% from the stock's current price.
View analysts price targets for CLNN or view top-rated stocks among Wall Street analysts.

Clene's stock was trading at $1.00 at the beginning of the year. Since then, CLNN shares have increased by 18.0% and is now trading at $1.18.
View the best growth stocks for 2023 here.

Clene saw a drop in short interest in the month of February. As of February 28th, there was short interest totaling 1,870,000 shares, a drop of 37.9% from the February 13th total of 3,010,000 shares. Based on an average daily trading volume, of 926,400 shares, the short-interest ratio is presently 2.0 days. Approximately 6.7% of the company's stock are short sold.
View Clene's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023.
View our CLNN earnings forecast.

Clene Inc. (NASDAQ:CLNN) issued its quarterly earnings results on Monday, November, 8th. The company reported $0.42 earnings per share for the quarter, topping analysts' consensus estimates of ($0.20) by $0.62. The firm earned $0.11 million during the quarter, compared to the consensus estimate of $0.14 million. Clene had a negative trailing twelve-month return on equity of 4,043.36% and a negative net margin of 6,325.16%.

Clene trades on the NASDAQ under the ticker symbol "CLNN."

Clene's stock is owned by many different institutional and retail investors. Top institutional shareholders include Kepos Capital LP (0.47%), Susquehanna International Group LLP (0.00%), Geode Capital Management LLC (0.31%), Simplex Trading LLC (0.00%), Atom Investors LP (0.17%) and Millennium Management LLC (0.16%). Insiders that own company stock include Alison Mosca, David J Matlin, David J Matlin, General Resonance Llc, John Henry Stevens, Jonathon Gay, Robert Dee Etherington and Robert Glanzman.
View institutional ownership trends.

Shares of CLNN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CLNN stock can currently be purchased for approximately $1.18.

Clene (NASDAQ:CLNN) has a market capitalization of $90.78 million and generates $470,000.00 in revenue each year. The company earns $-29,920,000.00 in net income (profit) each year or ($0.45) on an earnings per share basis.

Clene's mailing address is UNIT 902 9/F LUCKY BUILDING 39 WELLINGTON STREET, HONG KONG K3, . The official website for the company is clene.com. The company can be reached via phone at 801-676-9695 or via email at ir@clene.com.